FDG PET Hybrid Imaging

Becker, Juliane; Schwarzenböck, Sarah M.; Krause, Bernd J.

doi:10.1007/978-3-030-42618-7_19

Cited by 22 publications

(13 citation statements)

References 151 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 18 F]FDG PET/CT is expected to play an important role in the early diagnosis of this disease and will contribute to the improvement of its prognosis. Furthermore, the value of [ 18 F]FDG PET/CT in therapeutic assessment should be investigated and established as with other malignant tumors (Becker et al 2020 ; Unterrainer et al 2020 ).…”

Section: Discussionmentioning

confidence: 99%

SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT

Okazaki

Yokoyama

Tsuchiya

et al. 2021

European J Hybrid Imaging

View full text Add to dashboard Cite

Background SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a distinct entity of undifferentiated thoracic malignancies newly introduced in 2015. Due to its unique clinical characteristic with aggressive thoracic tumor mostly observed in heavy smoker man with emphysema, with poor prognosis, many physicians are becoming increasingly aware of the disease; however, reports on 2-deoxy-2-[18F] fluoroglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) have been limited; thus, this disease is not yet widely known to nuclear medicine clinicians. As a first step in discussing the usefulness of [18F]FDG PET/CT for this disease, we present a case in which [18F]FDG PET/CT played a clinically important role. Case A 74-year-old heavy smoker man with an anamnesis of severe emphysema characterized by pleural thickening and abnormal enhancement in CT underwent 18F-FDG PET/CT for further examination. [18F]FDG-avid pleural nodules infiltrating into the chest wall were detected and pathologically diagnosed as SMARCA4-DTT with biopsy. Conclusion SMARCA4-deficient thoracic tumor should be considered in a [18F]FDG-avid aggressive thoracic tumor in heavy smoker men with emphysema.

show abstract

Section: Discussionmentioning

confidence: 99%

SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT

Okazaki

Yokoyama

Tsuchiya

et al. 2021

European J Hybrid Imaging

View full text Add to dashboard Cite

show abstract

“…The hybrid imaging modality PET/CT allows assessing molecular as well as morphologic information at the same time. So, PET/CT represents an efficient tool for whole-body staging and re-staging within one imaging modality [13,14].…”

Section: Discussionmentioning

confidence: 99%

Diagnostic performance of PET/CT in primary malignant bone tumors

Abdella

Elshafey

Sherif

et al. 2021

Egypt J Radiol Nucl Med

View full text Add to dashboard Cite

Background Nowadays, PET/CT plays a substantial role in the diagnosis of different types of tumor by its ability to provide combined functional and anatomic imaging in the same session. The purpose of this study is to evaluate the added value of PET/CT in staging and re-staging of primary malignant bone tumors. Results Out of the studied 40 patients, 7 patients were referred for primary staging of different types of histologically proven primary malignant bone tumors, their FDG-PET/CT studies yielded additional diagnostic information in 28.6% of them. Thirty three patients were referred either for assessment of treatment response or for follow-up to detect any viable lesions; FDG-PET/CT was more sensitive and specific than CT in follow-up and assessment of treatment response with PET/CT sensitivity 94.4%, specificity 86.7%, and total accuracy 90.9% and CT sensitivity 88.2%, specificity 81.2%, and total accuracy 84.8%. Conclusions PET/CT was an accurate imaging modality in evaluation of primary malignant bone tumors regarding tumor staging, assessment of therapeutic response and detection of metastatic disease as compared to CT.

show abstract

“…Hypermetabolic pathological processes are typically areas of malignancies and inflammations, which can be detected with high sensitivity. One interesting aspect of PET is that SUV max changes rapidly after the administration of one specific antineoplastic or anti-inflammatory therapy, making PET an optimal tool not only for diagnosis but also for therapy assessment, both early after onset or at the end of treatment [ 48 ].…”

Section: Fdg Pet/ct Imagingmentioning

confidence: 99%

Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline

Boriani

Zamparini

Albrizio³

et al. 2022

CMIR

View full text Add to dashboard Cite

: Spondylodiscitis is an infectious process which requires numerous health care professionals in order to be clearly diagnosed and eventually, successfully treated. It implies a variety of microbiological agents and condition; during the diagnostic workup it is difficult to correctly identify them, and the clinician has to rapidly choose the most correct treatment, in order to avoid permanent injuries to the patient. In this context it comes our review work: based on current guidelines and literature available we wanted to deeply understand the most proper use of Positron Emission Tomography with 18-Fluoro-deossi-glucose (FDG PET) in a patient with the suspect of spondylodiscitis. We wanted to review the role of FDG PET in the spondylodiscitis diagnosis and follow up in the context of the current guidelines.

show abstract

FDG PET Hybrid Imaging

Cited by 22 publications

References 151 publications

SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT

SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT

Diagnostic performance of PET/CT in primary malignant bone tumors

Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline

Contact Info

Product

Resources

About